SPRY
ARS Pharmaceuticals, Inc.5.28post−$0.04 (−0.75%)at close +$0.00 (+0.00%)
as of 23:00:10 UTCnext report Aug 11 · 6d
Earnings Room‹ back to SPRY
The report
fiscal Q2 2026 · from the company's noticeAug 11before open6days out
Expected movement
market-implied · at the Aug 4 close±20.9%is what the chain prices between now and the expiry below. Not a view we hold.
That span is 17days, so it covers the report plus the ordinary movement around it. The chain doesn't yet quote a second expiry we can separate the two with; the range narrows onto the report as it approaches.
expiry Aug 21 · first after the reportATM strike 5straddle 1.30ATM IV 138%× 0.85 straddle-to-rangespot 5.28
Blast radius
3 linked · N-PORT + EDGARIf SPRY moves ±20.9% over this report, these carry part of it. Fund rows are arithmetic on published holding weights — what an index fund does by construction. Company rows are ranked by disclosed tie strength.
Positioning
Butterfly LadderNo options positioning captured for this ticker yet. Open interest settles once daily — check back after the next capture, or open this room again tomorrow.
The record
expected in pale · actual in full color2/8reports moved further than the options market had pricedtypically ±7.4% realized vs ±13.6% priced
May 15 '26±11.3%→−6.5%×0.58
Mar 9 '26±22.8%→−0.1%×0.00
Nov 10 '25±18.0%→+0.3%×0.02
Aug 13 '25±14.4%→−5.0%×0.35
May 14 '25±11.9%→−9.4%×0.79
Mar 20 '25±11.8%→+22.8%×1.93
Jan 13 '25±9.4%→+0.2%×0.02
Nov 13 '24±8.8%→−15.2%×1.73
pale = implied the day beforeink = the next day's close× = realized ÷ implied
2-quarter memory
Q1 FY26 · reported -0.61 · rev $23M
record note
The note composes when the report lands. Nothing is written for a quarter that hasn't been read.